Episode Details

Back to Episodes
What Science Says About Ketamine’s Risks and Benefits

What Science Says About Ketamine’s Risks and Benefits

Published 1 year, 6 months ago
Description

Ketamine is perhaps best known as a party drug, and it has long been used in hospitals as an anesthetic. In recent years, it has also been touted as a promising, experimental psychiatric treatment. But when Friends actor Matthew Perry overdosed on ketamine last year, it exposed a network of unregulated clinics and unscrupulous doctors distributing the drug for off-label uses. In this hour, we’ll talk with experts about what we know — so far — about ketamine’s efficacy and safety.

Guests:

Smita Das, clinical associate professor of psychiatry and behavioral sciences, Stanford Medicine; vice president of complex care and psychiatry, Lyra Health

Gerard Sanacora, professor of psychiatry and director, Yale Depression Research Program at the Yale School of Medicine

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us